BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29309627)

  • 1. Functional Defects From Endocrine Disease-Associated Mutations in HLXB9 and Its Interacting Partner, NONO.
    Kharade SS; Parekh VI; Agarwal SK
    Endocrinology; 2018 Feb; 159(2):1199-1212. PubMed ID: 29309627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b).
    Desai SS; Kharade SS; Parekh VI; Iyer S; Agarwal SK
    J Biol Chem; 2015 Oct; 290(42):25595-608. PubMed ID: 26342078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators.
    Shi K; Parekh VI; Roy S; Desai SS; Agarwal SK
    Endocr Relat Cancer; 2013 Feb; 20(1):111-22. PubMed ID: 23419452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-3β protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation.
    Desai SS; Modali SD; Parekh VI; Kebebew E; Agarwal SK
    J Biol Chem; 2014 Feb; 289(9):5386-98. PubMed ID: 24425879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα).
    Pham DH; Tan CC; Homan CC; Kolc KL; Corbett MA; McAninch D; Fox AH; Thomas PQ; Kumar R; Gecz J
    Hum Mol Genet; 2017 Jun; 26(11):2042-2052. PubMed ID: 28334947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer.
    de Silva HC; Lin MZ; Phillips L; Martin JL; Baxter RC
    Cell Mol Life Sci; 2019 May; 76(10):2015-2030. PubMed ID: 30725116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of NONO induces apoptosis, suppressing growth and invasion in esophageal squamous cell carcinoma.
    Cheng R; Zhu S; Guo S; Min L; Xing J; Guo Q; Li P; Zhang S
    Oncol Rep; 2018 Jun; 39(6):2575-2583. PubMed ID: 29620226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered stoichiometry and nuclear delocalization of NonO and PSF promote cellular senescence.
    Huang CJ; Das U; Xie W; Ducasse M; Tucker HO
    Aging (Albany NY); 2016 Dec; 8(12):3356-3374. PubMed ID: 27992859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of SOCS3 with NonO attenuates IL-1beta-dependent MUC8 gene expression.
    Song KS; Kim K; Chung KC; Seol JH; Yoon JH
    Biochem Biophys Res Commun; 2008 Dec; 377(3):946-51. PubMed ID: 18952062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
    Lu JY; Sewer MB
    Mol Cell Biol; 2015 Apr; 35(7):1223-37. PubMed ID: 25605330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rasd1 modulates the coactivator function of NonO in the cyclic AMP pathway.
    Ong SA; Tan JJ; Tew WL; Chen KS
    PLoS One; 2011; 6(9):e24401. PubMed ID: 21915321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SFPQ•NONO and XLF function separately and together to promote DNA double-strand break repair via canonical nonhomologous end joining.
    Jaafar L; Li Z; Li S; Dynan WS
    Nucleic Acids Res; 2017 Feb; 45(4):1848-1859. PubMed ID: 27924002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A coactivator trap identifies NONO (p54nrb) as a component of the cAMP-signaling pathway.
    Amelio AL; Miraglia LJ; Conkright JJ; Mercer BA; Batalov S; Cavett V; Orth AP; Busby J; Hogenesch JB; Conkright MD
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20314-9. PubMed ID: 18077367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer.
    Alfano L; Caporaso A; Altieri A; Costa C; Forte IM; Iannuzzi CA; Barone D; Esposito L; Giordano A; Pentimalli F
    J Cell Physiol; 2018 May; 233(5):4338-4344. PubMed ID: 29150959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-POU Domain-Containing Octamer-Binding Protein Negatively Regulates HIV-1 Infection in CD4(+) T Cells.
    St Gelais C; Roger J; Wu L
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):806-16. PubMed ID: 25769457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression.
    Li D; Chen Y; Mei H; Jiao W; Song H; Ye L; Fang E; Wang X; Yang F; Huang K; Zheng L; Tong Q
    Oncogene; 2018 Aug; 37(35):4871-4886. PubMed ID: 29773901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A.
    Zhu Z; Zhao X; Zhao L; Yang H; Liu L; Li J; Wu J; Yang F; Huang G; Liu J
    Oncogene; 2016 Mar; 35(11):1399-410. PubMed ID: 26148231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects.
    Mircsof D; Langouët M; Rio M; Moutton S; Siquier-Pernet K; Bole-Feysot C; Cagnard N; Nitschke P; Gaspar L; Žnidarič M; Alibeu O; Fritz AK; Wolfer DP; Schröter A; Bosshard G; Rudin M; Koester C; Crestani F; Seebeck P; Boddaert N; Prescott K; ; Hines R; Moss SJ; Fritschy JM; Munnich A; Amiel J; Brown SA; Tyagarajan SK; Colleaux L
    Nat Neurosci; 2015 Dec; 18(12):1731-6. PubMed ID: 26571461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NONO regulates the intra-S-phase checkpoint in response to UV radiation.
    Alfano L; Costa C; Caporaso A; Altieri A; Indovina P; Macaluso M; Giordano A; Pentimalli F
    Oncogene; 2016 Feb; 35(5):567-76. PubMed ID: 25893301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subnuclear re-localization of SOX10 and p54NRB correlates with a unique neurological phenotype associated with SOX10 missense mutations.
    Chaoui A; Kavo A; Baral V; Watanabe Y; Lecerf L; Colley A; Mendoza-Londono R; Pingault V; Bondurand N
    Hum Mol Genet; 2015 Sep; 24(17):4933-47. PubMed ID: 26060192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.